Schedule 13G ownership disclosure

ClearPoint Neuro Inc

Common Stock · CUSIP: 18507C103

Event date: 2025-06-30

Filing-level shares
1,475,120
Percent of class
5.27%
  • The Vanguard Group

    Shares: 1,475,120 · Class: 5.27%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000819
Form type
SCHEDULE 13G
Filer
ClearPoint Neuro, Inc.
CIK
CIK 1285550
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub